financetom
Business
financetom
/
Business
/
Royal Gold Q2 revenue misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Royal Gold Q2 revenue misses estimates
Aug 6, 2025 3:11 PM

Overview

* Royal Gold ( RGLD ) Q2 revenue rises to $209.6 mln, missing analyst expectations, per LSEG data

* Adjusted net income for Q2 misses estimates, per LSEG data

* Co announced acquisitions of Sandstorm Gold and Horizon Copper for growth

Outlook

* Company forecasts 2025 metal sales within previously provided ranges

* Royal Gold ( RGLD ) expects DD&A and effective tax rate to remain as forecasted

* Both gold and copper production are expected to be weighted towards the second half of the year

* Royal Gold ( RGLD ) anticipates growth from recent acquisitions

Result Drivers

* PRECIOUS METAL PRICES - Record revenue driven by strong gold and silver prices, per CEO Bill Heissenbuttel

* PRODUCTION INCREASE - Higher gold production from Peñasquito and Manh Choh contributed to revenue growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Miss $209.60 $225.20

Revenue mln mln (2

Analysts

)

Q2 EPS $2.01

Q2 Miss $118.80 $119.80

Adjusted mln mln (1

Net Analyst)

Income

Q2 Net $132.30

Income mln

Q2 $152.80

Adjusted mln

Free

Cash

Flow

Q2 $0.45

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the gold peer group is "buy"

* Wall Street's median 12-month price target for Royal Gold Inc ( RGLD ) is $215.00, about 25.5% above its August 5 closing price of $160.18

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 26 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ultragenyx Pharmaceutical Prices $350 Million Offering
Ultragenyx Pharmaceutical Prices $350 Million Offering
Jun 14, 2024
05:18 AM EDT, 06/14/2024 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said late Thursday it has priced an underwritten public offering of 7.4 million common shares at $39 per share for expected gross proceeds of about $350 million. The company is offering pre-funded warrants, in lieu of common stock to certain investors, to purchase about 1.5 million shares at...
Pfizer's Phase 2 MagnetisMM-3 Study of ELREXFIO Shows Median Overall Survival of Over 2 Years
Pfizer's Phase 2 MagnetisMM-3 Study of ELREXFIO Shows Median Overall Survival of Over 2 Years
Jun 14, 2024
05:21 AM EDT, 06/14/2024 (MT Newswires) -- Pfizer ( PFE ) said Friday that results from the phase 2 MagnetisMM-3 study of ELREXFIO in patients with heavily pretreated relapsed or refractory multiple myeloma showed a median overall survival of 24.6 months, with median progression-free survival of 17.2 months. After more than two years of follow-up in the MagnetisMM-3 trial, the...
Avidity Biosciences Prices $400.9 Million Offering of Shares
Avidity Biosciences Prices $400.9 Million Offering of Shares
Jun 14, 2024
05:28 AM EDT, 06/14/2024 (MT Newswires) -- Avidity Biosciences ( RNA ) said late Thursday it priced an offering of almost 10.6 million shares at $38 apiece for expected gross proceeds of $400.9 million. The company granted underwriters a 30-day option to purchase up to about 1.6 million additional shares in the offering. The sale will likely close on or...
CRH Gains Shareholder Approval for Acquisition of Adbri
CRH Gains Shareholder Approval for Acquisition of Adbri
Jun 14, 2024
05:26 AM EDT, 06/14/2024 (MT Newswires) -- CRH (CRH) said Friday that Adbri's independent shareholders have approved a plan through which it will acquire a majority stake in Adbri for 1.1 billion Australian dollars ($727.3 million). The plan received court approval on Friday. The deal has already secured regulatory approval and is expected to close on July 1, 2024. Under...
Copyright 2023-2026 - www.financetom.com All Rights Reserved